Enzyme replacement prevents enamel defects in hypophosphatasia mice

J Bone Miner Res. 2012 Aug;27(8):1722-34. doi: 10.1002/jbmr.1619.

Abstract

Hypophosphatasia (HPP) is the inborn error of metabolism characterized by deficiency of alkaline phosphatase activity, leading to rickets or osteomalacia and to dental defects. HPP occurs from loss-of-function mutations within the gene that encodes the tissue-nonspecific isozyme of alkaline phosphatase (TNAP). TNAP knockout (Alpl(-/-), aka Akp2(-/-)) mice closely phenocopy infantile HPP, including the rickets, vitamin B6-responsive seizures, improper dentin mineralization, and lack of acellular cementum. Here, we report that lack of TNAP in Alpl(-/-) mice also causes severe enamel defects, which are preventable by enzyme replacement with mineral-targeted TNAP (ENB-0040). Immunohistochemistry was used to map the spatiotemporal expression of TNAP in the tissues of the developing enamel organ of healthy mouse molars and incisors. We found strong, stage-specific expression of TNAP in ameloblasts. In the Alpl(-/-) mice, histological, µCT, and scanning electron microscopy analysis showed reduced mineralization and disrupted organization of the rods and inter-rod structures in enamel of both the molars and incisors. All of these abnormalities were prevented in mice receiving from birth daily subcutaneous injections of mineral-targeting, human TNAP at 8.2 mg/kg/day for up to 44 days. These data reveal an important role for TNAP in enamel mineralization and demonstrate the efficacy of mineral-targeted TNAP to prevent enamel defects in HPP.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alkaline Phosphatase / deficiency
  • Alkaline Phosphatase / metabolism
  • Alkaline Phosphatase / therapeutic use*
  • Animals
  • Dental Enamel / diagnostic imaging
  • Dental Enamel / embryology
  • Dental Enamel / enzymology
  • Dental Enamel / pathology*
  • Enzyme Replacement Therapy*
  • Humans
  • Hypophosphatasia / prevention & control*
  • Hypophosphatasia / therapy*
  • Immunoglobulin G / therapeutic use*
  • Immunohistochemistry
  • Incisor / diagnostic imaging
  • Incisor / pathology
  • Incisor / ultrastructure
  • Mice
  • Minerals / metabolism
  • Molar / diagnostic imaging
  • Molar / pathology
  • Molar / ultrastructure
  • Protein Transport
  • Recombinant Fusion Proteins / therapeutic use*
  • X-Ray Microtomography

Substances

  • Immunoglobulin G
  • Minerals
  • Recombinant Fusion Proteins
  • ALPL protein, mouse
  • Alkaline Phosphatase
  • asfotase alfa